Miko NV (LON:0F99)
52.80
0.00 (0.00%)
At close: Oct 27, 2025
Miko NV Revenue
Miko NV had revenue of 155.14M EUR in the half year ending June 30, 2025, with 25.50% growth. This brings the company's revenue in the last twelve months to 293.98M, up 9.70% year-over-year. In the year 2024, Miko NV had annual revenue of 276.69M with 9.04% growth.
Revenue (ttm)
293.98M EUR
Revenue Growth
+9.70%
P/S Ratio
0.23
Revenue / Employee
218.73K EUR
Employees
1,344
Market Cap
57.15M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 276.69M | 22.94M | 9.04% |
| Dec 31, 2023 | 253.75M | -12.05M | -4.53% |
| Dec 31, 2022 | 265.80M | 119.21M | 81.32% |
| Dec 31, 2021 | 146.59M | 52.64M | 56.03% |
| Dec 31, 2020 | 93.95M | -130.43M | -58.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |